Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Gene Therapy

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301324PMID 11127581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene therapy in rheumatic diseases.

  2001cited by this paper
• Viral IL-10 and Soluble TNF Receptor Act Synergistically to Inhibit Collagen-Induced Arthritis Following Adenovirus- Mediated Gene Transfer1

  2000cited by this paper
• Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist.

  2000cited by this paper
• The type II decoy receptor of IL‐1 inhibits murine collagen‐induced arthritis

  2000cited by this paper
• Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis.

  2000cited by this paper
• Future trends in the treatment of rheumatoid arthritis: cytokine targets.

  1999cited by this paper
• A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

  1999cited by this paper
• Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

  1999cited by this paper
• Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced Th2activity

  1999cited by this paper
• Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.

  1999cited by this paper
• Effect of nimesulide on glucocorticoid receptor activity in human synovial fibroblasts.

  1999cited by this paper
• Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.

  1999cited by this paper
• Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis.

  1999cited by this paper
• Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

  1999cited by this paper
• Adeno-Associated Viral Vectors for Gene Transfer and Gene Therapy

  1999cited by this paper
• A proinflammatory role for IL-18 in rheumatoid arthritis.

  1999cited by this paper
• Feasibility of Adenovirus-Mediated Nonsurgical Synovectomy in Collagen-Induced Arthritis-Affected Rhesus Monkeys

  1999cited by this paper
• Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration.

  1999cited by this paper
• Immune responses to adenovirus and adeno-associated virus in humans

  1999cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

  1999cited by this paper
• Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees.

  1999cited by this paper
• Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws.

  1999cited by this paper
• Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL‐4 or IL‐13 ameliorates murine collagen‐induced arthritis (CIA)

  1999cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

  1999cited by this paper
• Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts.

  1998cited by this paper
• Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects.

  1998cited by this paper
• Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates

  1998cited by this paper
• Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

  1998cited by this paper
• Modulation of proinflammatory cytokine production in tumour necrosis factor‐alpha (TNF‐α)‐transgenic mice by treatment with cells engineered to secrete IL‐4, IL‐10 or IL‐13

  1998cited by this paper
• Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis.

  1998cited by this paper
• Gene Inhibits Murine Collagen-Induced Arthritis Adenovirus-Mediated Transfer of Viral IL-10

  1998cited by this paper
• Biochemical recovery and purification of gene therapy vectors.

  1998cited by this paper
• Gene therapy for rheumatic diseases.

  1998cited by this paper
• Peroral gene therapy of lactose intolerance using an adeno-associated virus vector

  1998cited by this paper
• Factors Influencing Recombinant Adeno-Associated Virus Production

  1998cited by this paper
• Inducible long-term gene expression in brain with adeno-associated virus gene transfer

  1998cited by this paper
• Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13.

  1998cited by this paper
• Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers

  1998cited by this paper
• Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.

  1997cited by this paper
• Suppression of collagen-induced arthritis by continuous administration of IL-4.

  1997cited by this paper
• Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen‐induced arthritis

  1997cited by this paper
• Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee.

  1997cited by this paper
• Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

  1997cited by this paper
• Recombinant adeno-associated virus for muscle directed gene therapy

  1997cited by this paper
• Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice.

  1997cited by this paper
• Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis

  1997cited by this paper
• Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration

  1997cited by this paper
• High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors.

  1997cited by this paper
• Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent Mice

  1997cited by this paper
• Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen‐induced arthritis

  1996cited by this paper
• Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.

  1996cited by this paper
• Interleukin-10 inhibition of the progression of established collagen-induced arthritis.

  1996cited by this paper
• Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy.

  1996cited by this paper
• Strategies for the isolation and purification of retroviral vectors for gene therapy.

  1996cited by this paper
• Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

  1996cited by this paper
• Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice

  1996cited by this paper
• Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13

  1996cited by this paper
• Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

  1996cited by this paper
• Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.

  1996cited by this paper
• Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.

  1995cited by this paper
• Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.

  1995cited by this paper
• Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes.

  1995cited by this paper
• Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis.

  1995cited by this paper
• Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis

  1995cited by this paper
• Current protocols in human genetics

  1994cited by this paper
• Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.

  1993cited by this paper
• Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis.

  1993cited by this paper
• Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells.

  1993cited by this paper
• Arthritogenicity of minor cartilage collagens (types IX and XI) in mice.

  1990cited by this paper
• Rheumatoid arthritis. Pathophysiology and implications for therapy.

  1990cited by this paper
• Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis.

  1987cited by this paper
• Immunisation against heterologous type II collagen induces arthritis in mice

  1980cited by this paper
• Autoimmunity to type II collagen an experimental model of arthritis

  1977cited by this paper

• Peripheral T-cell responses of EphB2- and EphB3-deficient mice in a model of collagen-induced arthritis

  2024cites this paper
• Treatment of Rheumatoid Arthritis with Gene Therapy Applications: Biosafety and Bioethical Considerations

  2021cites this paper
• Toward gene therapy in rheumatoid arthritis

  2020cites this paper
• Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A

  2019cites this paper
• Gene Therapy in Cartilage Repair and Regeneration

  2018cites this paper
• Arthritis models: usefulness and interpretation

  2017cites this paper
• 10 Gene Therapy Challenges in Arthritis

  2017cites this paper
• In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis

  2016cites this paper
• Apolipoprotein A-V gene therapy for disease prevention / treatment: a critical analysis

  2015cites this paper
• Prediction of Adeno-Associated Virus Neutralizing Antibody Activity for Clinical Application

  2015cites this paper
• Intra-articular delivery of anti-Hif-2α siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice

  2015cites this paper
• IL-4 Modulates Macrophage Polarization in Ankylosing Spondylitis

  2015cites this paper
• Suppression of Development of Ankylosing Spondylitis Through Soluble Flt-1

  2015cites this paper
• Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology

  2015cites this paper
• Super-resolution imaging of nuclear import of adeno-associated virus in live cells

  2015cites this paper
• Molecular and cell-based therapies for muscle degenerations: a road under construction

  2014cites this paper
• RNAi-Mediated Silencing of Atp6i and Atp6i Haploinsufficiency Prevents Both Bone Loss and Inflammation in a Mouse Model of Periodontal Disease

  2013cites this paper
• Inhibiting Periapical Lesions through AAV-RNAi Silencing of Cathepsin K

  2013cites this paper
• AAV2-Mediated Combined Subretinal Delivery of IFN-α and IL-4 Reduces the Severity of Experimental Autoimmune Uveoretinitis

  2012cites this paper
• Establishment of Recombinant Adeno-Associated Virus Vector Integration Frequency In Vitro and In Vivo

  2012cites this paper
• Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model.

  2012cites this paper
• Modèle d’arthrite au collagène chez le rat : le transfert du gène codant pour l’ostéoprotégérine via des virus adeno-associated protège contre la destruction articulaire

  2012cites this paper
• Diverse Effects of DNA Repair Pathways on the Outcome of Recombinant Adeno-Associated Virus (rAAV) Vector Gene Delivery

  2011cites this paper
• Effector T cells in rheumatoid arthritis: Lessons from animal models

  2011cites this paper
• Gene Therapy Challenges in Arthritis

  2011cites this paper
• Therapeutic gene transfer for rheumatoid arthritis.

  2011cites this paper
• Gene Therapy for Rheumatoid Arthritis

  2011cites this paper
• Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment

  2010cites this paper
• Development of AAV vectors for the therapy of autoimmune and inflammatory diseases

  2010cites this paper
• Gene therapy for osteoarthritis

  2010cites this paper
• Intra‐articular electrotransfer of mouse soluble tumour necrosis factor receptor in a murine model of rheumatoid arthritis

  2010cites this paper
• Prospects for gene therapy in inflammatory arthritis.

  2010cites this paper
• Gene therapy for arthritis

  2010cites this paper
• Optimizing adeno-associated virus as a gene therapy vector for treating arthritis

  2009cites this paper
• Intra‐articular gene delivery and expression of interleukin‐1Ra mediated by self‐complementary adeno‐associated virus

  2009cites this paper
• Biotechnological Approaches for the Treatment of Inflammatory Diseases

  2009cites this paper
• CD4+CD25+ Regulatory T Cells as Adoptive Cell Therapy for Autoimmune Disease and for the Treatment of Graft-Versus-Host Disease

  2008cites this paper
• Perspectives on the use of gene therapy for chronic joint diseases.

  2008cites this paper
• IGF-1 gene therapy to protect articular cartilage in a rat model of joint damage

  2008cites this paper
• Viral, Nonviral, and Physical Methods for Gene Delivery

  2008cites this paper
• Gene therapy for arthritis

  2008cites this paper
• The use of recombinant adeno-associated virus for skeletal gene therapy.

  2007cites this paper
• Utility of animal models for identification of potential therapeutics for rheumatoid arthritis

  2007cites this paper
• Local gene therapy for the treatment of arthritis

  2007cites this paper
• Gene therapy for rheumatoid arthritis

  2007cites this paper
• Synoviocyte Infection with Adeno-Associated Virus (AAV) Is Neutralized by Human Synovial Fluid from Arthritis Patients and Depends on AAV Serotype

  2007cites this paper
• Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.

  2006cites this paper
• AAV-mediated gene transfer to synovium: enhancing effects of inflammatory cytokines and proteasome inhibitors

  2006cites this paper
• Treatment of human disease by adeno-associated viral gene transfer

  2006cites this paper
• Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.

  2006influential citation
• Relationship between angiogenesis and inflammation in experimental arthritis.

  2006cites this paper
• Gene therapy for arthritis: what next?

  2006cites this paper
• Gene therapy for patients with rheumatoid arthritis.

  2006cites this paper
• Technology Insight: gene transfer and the design of novel treatments for rheumatoid arthritis

  2006cites this paper
• Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo.

  2005cites this paper
• Thrombospondin 1 as an effective gene therapeutic strategy in collagen-induced arthritis.

  2005cites this paper
• GENE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS IN NZB/W F1 MICE

  2005cites this paper
• AAV hybrid serotypes: improved vectors for gene delivery.

  2005cites this paper
• La thérapie génique au service de la polyarthrite rhumatoïde

  2005cites this paper
• Gene Therapy Approaches for Autoimmune Diseases of the Central Nervous System and Other Tissues

  2005cites this paper
• Adeno-Associated Virus Pseudotype 5 Vector Improves Gene Transfer in Arthritic Joints

  2005cites this paper
• Suppression of adenoviral gene expression in the liver: role of innate vs adaptive immunity and their cell lysis mechanisms

  2005cites this paper
• Immune Response Against Gene Therapy Vectors: Influence of Synovial Fluid on Adeno-Associated Virus Mediated Gene Transfer to Chondrocytes

  2004cites this paper
• Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4.

  2004cites this paper
• The usefulness and the limitations of animal models in identifying targets for therapy in arthritis.

  2004cites this paper
• Interleukin-4 Cellular Gene Therapy and Osteoprotegerin Decrease Inflammation-Associated Bone Resorption in Collagen-Induced Arthritis

  2004cites this paper
• Gene Therapy of Collagen-Induced Arthritis by Electrotransfer of Human Tumor Necrosis Factor-α Soluble Receptor I Variants

  2004cites this paper
• Gene therapy for autoimmune diseases.

  2004cites this paper
• Recombinant adeno-associated virus preferentially transduces human, compared to mouse, synovium: implications for arthritis therapy

  2004cites this paper
• Recent developments in molecular therapeutic approaches for rheumatoid arthritis.

  2004cites this paper
• Therapeutic gene transfer for rheumatoid arthritis La terapia genica nell'artrite reumatoide

  2004cites this paper
• Vectors for the treatment of autoimmune disease

  2003cites this paper
• Interleukin-4-induced apoptosis entails caspase activation and suppression of extracellular signal-regulated kinase phosphorylation.

  2003cites this paper
• Les outils de la thérapie génique des maladies articulaires

  2003cites this paper
• Biology and pathology of the temporomandibular joint: is there an animal model to study this affliction?

  2003cites this paper
• Möglichkeiten der Gentherapie

  2003cites this paper
• GENE THERAPY FOR RHEUMATOID ARTHRITIS Lessons from Animal Models , Including Studies on Interleukin-4 , Interleukin-10 , and Interleukin-1 Receptor Antagonist as Potential Disease Modulators

  2003cites this paper
• Methods for the in vitro determination of an individual disposition towards TH1‐ or TH2‐reactivity by the application of appropriate stimulatory antigens

  2003cites this paper
• Vectors for gene therapy of joint disorders.

  2003cites this paper
• Gene transfer as a future therapy for rheumatoid arthritis

  2003cites this paper
• Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4.

  2002cites this paper
• Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes.

  2002cites this paper
• High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.

  2002cites this paper
• Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators.

  2002cites this paper
• The potential for gene therapy in the treatment of autoimmune disease.

  2002cites this paper
• Syngeneic fibroblasts transfected with a plasmid encoding interleukin‐4 as non‐viral vectors for anti‐inflammatory gene therapy in collagen‐induced arthritis

  2002cites this paper
• Gene therapy for rheumatoid arthritis

  2002cites this paper
• Exposure to receptor-activator of NFκB ligand renders pre-osteoclasts resistant to IFN-γ by inducing terminal differentiation

  2002cites this paper
• GENE THERAPY FOR

  2002cites this paper
• Tetracycline-Inducible Interleukin-10 Gene Transfer Mediated by an Adeno-Associated Virus: Application to Experimental Arthritis

  2002cites this paper
• High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets

  2002influential citation
• Gene therapy in orthopaedic surgery.

  2002cites this paper
• Development of gene-based therapies for cartilage repair.

  2002cites this paper
• AAV-MEDIATED GENE TRANSFER TO MODELS OF MUSCULAR DYSTROPHY: INSIGHTS INTO ASSEMBLY OF MULTI-SUBUNIT MEMBRANE PROTEINS.

  2002cites this paper
• Adoptive cellular gene therapy of autoimmune disease.

  2002cites this paper
• Anticytokine gene therapy of autoimmune diseases

  2001cites this paper
• Gene therapy for autoimmune disease.

  2001cites this paper
• Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis

  2001cites this paper
• Construction and identification of the recombinant of the AAV vector and human interferon-gamma

  2001cites this paper
• Aspects éthiques de la thérapie génique en rhumatologie

  2001cites this paper